Pending AI is Building a World-First Drug Discovery and Development Platform Enabled by Scalable Quantum Mechanics and Artificial Intelligence.
Built by world-class scientific and engineering innovators
Actively partnering with pharmaceutical companies for asset co-development
Broad-spectrum discovery platform capable of developing medicines for any disease
Trusted by people who back the future
Our Offices
Pending AI operates across Boston, Massachusetts, United States and Sydney, New South Wales, Australia. With a global presence, our company is well-positioned to develop higher-quality medicines for underserved diseases.